Dr. Gregory Aarons
@drgregaarons.bsky.social
430 followers 120 following 45 posts
Implementation research, runner, editor @Implementation Science, funded by NCI, NIDA, NIMH, FIC, working to improve domestic & global health through implementation science, https://episframework.com/, https://www.implementationleadership.com/
Posts Media Videos Starter Packs
drgregaarons.bsky.social
Adverse childhood experiences (ACES) are linked to lifespan physical & mental health problems. This study led by Monica Perez-Jolles improved ACES screening outcomes using a multi-faceted implementation strategy. @ucsd-disc.bsky.social @accordsresearch.bsky.social link.springer.com/article/10.1...
Testing a multi-faceted strategy to support the implementation of ACEs screenings in primary care: results of a stepped-wedge pilot trial - Implementation Science Communications
Background Adverse Childhood Experiences (ACEs) screenings are increasingly being used in primary care clinics to identify toxic stress and potential trauma in children. ACEs are negative life events (e.g., violence exposure) occurring before age 18, that can increase health risks when unaddressed. However, we lack evidence on the impact of ACEs screenings and how they can be feasibly implemented in community-based clinics. We partnered with federally qualified health clinics to test the impact of a multifaceted implementation strategy on ACEs screening reach and mental health referrals for children ages 0–5. Methods We conducted a Hybrid Type 2 pilot trial using a stepped-wedge design (2021–2024). Reach data was measured as the proportion of eligible children screened for ACEs, with data collected from Electronic Health Records. We also assessed the percentage of mental health service referrals among all eligible children. Study clinics (n = 3) switched from no ACEs screenings (control) to implementing ACEs screenings supported by the multi-faceted ACE implementation strategy (intervention). The tested strategy comprised personnel training (e.g., trauma-informed care), integrated technology, team-based screening workflows, and ongoing care team implementation support. Additional clinics (n = 2) implemented ACEs screenings as usual without the strategy and served as additional comparison sites for exploratory analyses. Log-binomial and robust Poisson regression models examined differences in screening reach and referrals and were adjusted for site and patient race. Results Screening reach rates increased in the intervention period, from 0.0% of patients screened during control to 11.2% screened during intervention. Mental health service referrals increased from 0.4% at control to 7.2% during the intervention, resulting in a risk difference (95% confidence interval) of 6.9% (6.0%, 7.7%). For both the reach and referral outcomes, risk differences were significantly greater for 18-to-60-month-old patients than for patients under 18-months-old. Discussion Healthcare policy efforts promoting ACEs screenings in primary care are commendable. We found that a multi-faceted implementation strategy informed by partners and designed to support ACEs screenings in community-based clinics was feasible. However, its impact was attenuated by policy requirements, clinics’ capacity to add ACEs screenings to strained workflows, and multiple impactful outer-context events related and unrelated to the COVID-19 pandemic. Trial registration Trial # NCT04916587 registered at clinicaltrials.gov on June 4, 2021, https://clinicaltrials.gov/study/NCT04916587
link.springer.com
Reposted by Dr. Gregory Aarons
katejj.bsky.social
The University of Glasgow groundspeople are going to be quite annoyed when they come in to work tomorrow...
Reposted by Dr. Gregory Aarons
Reposted by Dr. Gregory Aarons
ucsd-disc.bsky.social
📢 Join us for the June EPIS Office Hours! We’re excited to welcome Dr. Marisa Sklar as our guest host this month! Please note: June’s office hours will be held at only one time point (8-9 am PT) drop by to ask questions and connect with an EPIS expert. #EPISFramework
Reposted by Dr. Gregory Aarons
annetteboaz.bsky.social
It’s @arc-southlondon.bsky.social Implementation Science Masterclass time @kingscollegelondon.bsky.social Big thanks to our colleagues joining from all over the world to share their expertise including @drgregaarons.bsky.social @grahammoore.bsky.social and many more 🙏
drgregaarons.bsky.social
Love Fog City
Diner. Glad that I went last fall when I was at a conference in SF. Will be missed...
drgregaarons.bsky.social
I am so looking forward to this fun event with creative ways to communicate about implementation science!
balbers.bsky.social
One of my highlights next week is The Science Slam at the 2025 European Implementation Event in Newcastle with a great lineup of slammers, including @drgregaarons.bsky.social - you can register for the #EIE2025 until tomorrow! #ImpSci
Reposted by Dr. Gregory Aarons
cei-global.bsky.social
Improving #implementation is key to overcoming #policy failure, write CEI experts Jane Lewis & Dr Robyn Mildon in a commentary for @schoolforgovt.bsky.social. #impsci #evidence #research #practice #scaling
schoolforgovt.bsky.social
"...we don't see the services, interventions and approaches that are of proven effectiveness being taken up, embedded and sustained at scale. This is implementation failure...It's there in every policy area, and it's profound."

Jane Lewis of @cei-global.bsky.social writes for our comment series
Reducing policy failure means addressing policy implementation
Services, interventions and approaches that are of proven effectiveness are not being taken up at scale
www.kcl.ac.uk
drgregaarons.bsky.social
drgregaarons.bsky.social
Please see our editorial led by @rsbeidas.bsky.social on the impact of US federal grant terminations on the field of implementation science in the US and globally. imphttps://implementationscience.biomedcentral.com/articles/10.1186/s13012-025-01434-7
Implementation science grant terminations in the United States - Implementation Science
implementationscience.biomedcentral.com
drgregaarons.bsky.social
Please see our editorial led by @rsbeidas.bsky.social on the impact of US federal grant terminations on the field of implementation science in the US and globally. imphttps://implementationscience.biomedcentral.com/articles/10.1186/s13012-025-01434-7
Implementation science grant terminations in the United States - Implementation Science
implementationscience.biomedcentral.com
drgregaarons.bsky.social
So important to have strong, intelligent, caring and courageous women role models. Especially now when government forces try to minimize the roles and value of women in society and life.
Reposted by Dr. Gregory Aarons
wordswithsteph.bsky.social
BREAKING UPDATE:
Wisconsin Attorney General Josh Kaul is suing Elon Musk to block his $1 million bribes to voters.

www.pbs.org/newshour/pol...
Reposted by Dr. Gregory Aarons
Reposted by Dr. Gregory Aarons
erikacrable.bsky.social
@mcuban.bsky.social this is a long shot but my account is small & the losses to science are too great to not ask for favors. Please consider getting the word out about AHRQ & NIH funding cuts. We are losing a generation of scientists & American innovation. Thanks! 🤞🙏
Reposted by Dr. Gregory Aarons
erikacrable.bsky.social
🙏 Shameless ask: It’s my birthday. Scientists, please call your Congress peeps & tell them why AHRQ & NIH are critical to curing cancer, treating & preventing substance use, ensuring healthcare access in rural America, the list goes on. Without real #AHRQ & #NIH funding we will be a sicker country.
academyhealth.bsky.social
🚨 AHRQ is feared to be the next target for mass layoffs by the Trump administration. The agency conducts essential research on rural health, nutrition, health care quality and costs, and lawmakers are taking the threat to its staffing seriously. Read more in STAT News:
HHS agency responsible for health care quality research threatened with mass layoffs
AHRQ, a small government agency responsible for health care quality research, is feared to be the latest target for mass layoffs by the Trump administration.
buff.ly
Reposted by Dr. Gregory Aarons
mcuban.bsky.social
From 2010 to 2016 (latest data I have ), NIH research contributed to EVERY drug approved by the FDA